Robert Spurr - Net Worth and Insider Trading
Robert Spurr Net Worth
The estimated net worth of Robert Spurr is at least $694,634 dollars as of 2024-12-27. Robert Spurr is the U.S. President-Pharma Business of Bausch Health Companies Inc and owns about 90,506 shares of Bausch Health Companies Inc (BHC) stock worth over $694,634. Details can be seen in Robert Spurr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Spurr has not made any transactions after 2022-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Spurr
Robert Spurr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Spurr owns 2 companies in total, including Bausch Health Companies Inc (BHC) , and Repligen Corp (RGEN) .
Click here to see the complete history of Robert Spurr’s form 4 insider trades.
Insider Ownership Summary of Robert Spurr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHC | Bausch Health Companies Inc | 2022-04-14 | director & U.S. President-Pharma Business |
| RGEN | Repligen Corp | 2012-03-12 | Chief Commercial. Officer |
Robert Spurr Latest Holdings Summary
Robert Spurr currently owns a total of 1 stock. Robert Spurr owns 90,506 shares of Bausch Health Companies Inc (BHC) as of April 14, 2022, with a value of $694,634.
Latest Holdings of Robert Spurr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHC | Bausch Health Companies Inc | 2022-04-14 | 90,506 | 7.68 | 694,634 |
Holding Weightings of Robert Spurr
Robert Spurr Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Spurr has made a total of 4 transactions in Bausch Health Companies Inc (BHC) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Bausch Health Companies Inc is the sale of 1,595 shares on April 14, 2022, which brought Robert Spurr around $35,393.
Insider Trading History of Robert Spurr
- 1
Robert Spurr Trading Performance
Robert Spurr Ownership Network
Robert Spurr Owned Company Details
What does Bausch Health Companies Inc do?
Who are the key executives at Bausch Health Companies Inc?
Robert Spurr is the director & U.S. President-Pharma Business of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .
Bausch Health Companies Inc (BHC) Insider Trades Summary
Over the past 18 months, Robert Spurr made no insider transaction in Bausch Health Companies Inc (BHC). Other recent insider transactions involving Bausch Health Companies Inc (BHC) include a net sale of 20,758 shares made by Seana Carson ,
In summary, during the past 3 months, insiders sold 440 shares of Bausch Health Companies Inc (BHC) in total and bought 0 shares, with a net sale of 440 shares. During the past 18 months, 20,758 shares of Bausch Health Companies Inc (BHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,758 shares.
Bausch Health Companies Inc (BHC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bausch Health Companies Inc Insider Transactions
Robert Spurr Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Spurr. You might contact Robert Spurr via mailing address: C/o Bausch Health Companies Inc., 400 Somerset Corporate Blvd., Bridgewater Nj 08807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
